Advances in soft materials are reshaping the design of next-generation devices, particularly where flexibility, adaptability, ...

Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...

Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some ...

Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some critical information is ...

Top line data readout expected in late Q3/early Q4; INFORM-MS trial is a randomized, double-blind, placebo-controlled Phase ...

Traditional SSVEP stimuli are essentially high‑contrast brightness modulations that strongly activate the occipital visual cortex, but they are ...

Capivasertib plus abiraterone/prednisone improved radiographic PFS in PTEN-deficient mAPMN/S prostate cancer (CAPItello-281) and launched with a VENTANA PTEN ...

Dental Piezoelectric Ultrasonic Unit Market is set to reach USD 265.1 million by 2026-end and grow at a CAGR of 5.0% between 2026-2036 ...

Lipid-based nanocarriers, particularly liposomes, have played a central role in the development of modern drug delivery ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced the completion of its ...